Along with these, several newly discovered BET/BrD inhibitors, such as FT-1101, CPI-0610, BAY 1238097, INCB054329 TEN-010, BAY-299, etc., are currently under various phases of cancer clinical trials [58]. The gene discussed is DNER; the disease is cancer.